Translating the cancer genome into clinically useful tools and strategies

DMM Disease Models and Mechanisms

Volumn 2, Issue 9-10, 2009, Pages 426-429

  Innocenti, Federico ^a   Schilsky, Richard L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; TUMOR MARKER;

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; EDITORIAL; EXPERIMENTAL MODEL; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; GLIOBLASTOMA; MOLECULAR INTERACTION; MUTATION; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HEALTH; SOMATIC MUTATION; TUMOR GENE;

BIOMEDICAL RESEARCH; CLINICAL MEDICINE; CLINICAL TRIALS AS TOPIC; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 70450197805     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.004119     Document Type: Editorial

References (15)

1. Chau, C. H., Rixe, O., McLeod, H. and Figg, W. D. (2008). Validation of analytic methods for biomarkers used in drug development. Clin. Cancer Res. 14, 5967-5976.
2. Chin, L. and Gray, J. W. (2008). Translating insights from the cancer genome into clinical practice. Nature 452, 553-563.
3. Dulbecco, R. A. (1986). Turning point in cancer research: sequencing the human genome. Science 231, 1055-1056.
4. Eberhard, D. A., Giaccone, G. and Johnson, B. E. (2008). Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. J. Clin. Oncol. 26, 983-994.
5. Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186.
6. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M. R. (2004). A census of human cancer genes. Nat. Rev. Cancer 4, 177-183.
7. Hodgson, D. R., Whittaker, R. D., Herath, A., Amakye, D. and Clack, G. (2009). Biomarkers in oncology drug development. Mol. Oncol. 3, 24-32.
8. Kim, T. W. and Innocenti, F. (2007). Insights, challenges, and future directions in irinogenetics. Ther. Drug Monit. 29, 265-270. (Pubitemid 47262254)
9. Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D., Dunford-Shore, B. H., McGrath, S., Hickenbotham, M. et al. (2008). DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66-72.
10. Nowell, P. and Hungerford, D. (1960). A minute chromosome in chronic granulocytic leukemia. Science 132, 1497.
11. Parsons, D. W., Jones, S., Zhang, X., Lin, J. C., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I. M., Gallia, G. L. et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812.
12. Rowley, J. D. (1973). Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293.
13. Sotiriou, C. and Pusztai, L. (2009). Gene-expression signatures in breast cancer. N. Engl. J. Med. 360, 790-800.
14. Stratton, M. R., Campbell, P. J. and Futreal, P. A. (2009). The cancer genome. Nature 458, 719-724.
15. Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I. and Kerr D. (2009). Genetic prognostic and predictive markers in colorectal cancer. Nat. Rev. Cancer 9, 489-499.